Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olodaterol (BI 1744) in COPD
NCT00782210Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Nov 2008; status: completed.
02
Drugs
olodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00782210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00782210.